Akero Therapeutics, Inc. Public Float
Akero Therapeutics, Inc. had Public Float of $1.57 trillion as of 2024-06-30, per its 10-K filed 2025-02-28.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2025-02-28
- 2024-06-30: Entity Public Float $1.57T.
- 2023-06-30: Entity Public Float $2.52B.
- 2022-06-30: Entity Public Float $340.43B.
- 2021-06-30: Entity Public Float $768.22M.
| Period end | Entity Public Float |
|---|---|
| 2024-06-30 | $1.57T 10-K · filed 2025-02-28 |
| 2023-06-30 | $2.52B 10-K · filed 2024-02-29 |
| 2022-06-30 | $340.43B 10-K · filed 2023-03-17 |
| 2021-06-30 | $768.22M 10-K/A · filed 2022-03-02 |
| 2020-06-30 | $477.92M 10-K · filed 2021-03-16 |
| 2019-06-28 | $195.94M 10-K · filed 2020-03-16 |